Skip to main content Help with accessibility Skip to main navigation

TRIPTORELIN (Decapeptyl® SR)

CCG Approval Status:

Date Added: 28 - Feb - 2018
Body System:
Amber retained

The Pan Mersey Area Prescribing Committee recommends that TRIPTORELIN (Decapeptyl® SR 3mg, 11.25mg and 22.5mg) INTRAMUSCULAR INJECTION is first choice gonadorelin analogue for prostate cancer following specialist urologist / oncologist initiation under applicable local arrangement.